Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
Drug-coated balloons (DCBs) have become an established therapy for the treatment of above-the-knee peripheral artery disease. The paclitaxel DCB has shown clinical benefit in terms of patency and freedom from re-intervention in multiple randomised trials. However, a recent meta-analysis has suggeste...
Saved in:
| Main Authors: | Masayuki Mori, Atsushi Sakamoto, Rika Kawakami, Yu Sato, Hiroyuki Jinnouchi, Kenji Kawai, Anne Cornelissen, Renu Virmani, Aloke V Finn |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Radcliffe Medical Media
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f91c206208b44a8a880d3e366e62a358 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IN.PACTTM AdmiralTM drug-coated balloons in peripheral artery disease: current perspectives
by: Torii S, et al.
Published: (2019) -
A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions.
by: Ole Gemeinhardt, et al.
Published: (2021) -
A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions
by: Ole Gemeinhardt, et al.
Published: (2021) -
Treatment of cephalic arch stenosis in dysfunctional arteriovenous fistulas with paclitaxel-coated versus conventional balloon angioplasty
by: Ren Kwang A. Tng, et al.
Published: (2021) -
Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
by: Xinlin Zhang, et al.
Published: (2014)